Ondansetron 4 mg/5mL (Ondansetron SOLUTION) 4 mg/5mL

Ondansetron 4 mg/5mL is an oral solution used to prevent nausea and vomiting. This antiemetic medication is available in unit-dose syringes for convenient administration.

Strength

4 mg/5mL

Pack Size

48 SYRINGE in 1 BOX, UNIT-DOSE (17856-0691-7) / 1.9 mL in 1 SYRINGE

Manufacturer / TM Owner

ATLANTIC BIOLOGICALS CORP.

Select Quantity

Pack/s

Request a Quote

Please fill out the form below and our team will get back to you shortly with pricing and further information.

First Name

Last Name

Phone

Delivery Country

Delivery PostCode/Zipcode

Select Your Profile

I have read and agree to the terms & conditions, including the privacy policy, return policy, and usage terms as applicable to this request.

Indications & Clinical Uses

Ondansetron 4 mg/5mL is commonly used to prevent nausea and vomiting caused by various factors, including chemotherapy, radiation therapy, and surgery. It works by blocking serotonin receptors in the brain, which helps to reduce feelings of nausea. This medication is often prescribed for patients undergoing treatments that commonly induce nausea and vomiting.

Side Effects

Ondansetron 4 mg/5mL may cause common side effects such as headache, dizziness, and constipation. Some users may also experience diarrhea or fatigue. These effects vary from person to person and are generally mild to moderate in nature.

Precautions & Warnings

Ondansetron 4 mg/5mL should be used with caution in individuals with a history of heart conditions or electrolyte imbalances. It is important to follow the prescribed dosage and administration instructions provided by a healthcare professional. Store the medication at room temperature and keep it out of reach of children.

Avoid Interactions

Ondansetron 4 mg/5mL may interact with other medications, including apomorphine, which can cause a severe drop in blood pressure. It is important to inform your healthcare provider about all medications you are taking to avoid potential interactions. Alcohol should be avoided while using this medication.

Frequently Asked Questions

Ondansetron 4 mg/5mL is used to prevent nausea and vomiting caused by chemotherapy, radiation therapy, and surgery.

Ondansetron 4 mg/5mL is administered orally using the provided unit-dose syringes. Follow the instructions provided by your healthcare professional.

Common side effects include headache, dizziness, constipation, diarrhea, and fatigue.

Ondansetron 4 mg/5mL may interact with other medications, so it is important to inform your healthcare provider about all medications you are taking.

Store Ondansetron 4 mg/5mL at room temperature and keep it out of reach of children.

Published by

GNH India Pharmaceuticals Limited

Licensed pharmaceutical supplier

Last updated: 29 Jul 2026

Disclaimer

At GNH India, we aim to provide information that is expert-reviewed, accurate, and reliable. However, all content on this platform is intended for general informational purposes only and does not constitute professional medical advice, diagnosis, or treatment. While efforts are made to maintain accuracy and currency, the information may contain errors, omissions, or may not reflect the latest developments. Always consult a qualified healthcare professional regarding any medical concerns.

All product names, brand names, trademarks and registered trademarks displayed on this website are the property of their respective owners. This website and its operator are not affiliated with, endorsed by, or authorized by any such trade mark owners unless expressly stated. Any reference to product names or trademarks is made solely for descriptive and informational purposes. No commercial relationship, sponsorship, approval, or association with any trademark owner should be inferred. Information provided herein does not constitute promotion, advertising, or an offer for sale of any medicinal product and is intended solely for general informational purposes.

All trademarks and brand names displayed on this website are used strictly in accordance with the provisions of the Trade Marks Act, 1999, specifically Sections 30 and 30(1) governing fair use. Trademark ownership has been accurately attributed under the "Manufacturer/ TM Owner" section in compliance with statutory requirements.